ALF-1

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameALF-1
Drug Alias NameALF-1
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionTGF-β activated kinase-1 inhibitorsToll like receptor 4 inhibitorsMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinaseTGF-β activated kinase-1Toll like receptor 4
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A